← Open Payments lookup

JOSHUA ODERANTI: Open Payments

NPI 1114441102 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,311 in 17 payments from 11 companies in 2025. Trend: 2023 $317 · 2024 $660 · 2025 $1,311

Food & beverage: $1,311
CompanyPaymentsAmount
Janssen Biotech, Inc.4$419
GlaxoSmithKline, LLC.2$245
Pharmacosmos Therapeutics Inc.2$241
E.R. Squibb & Sons, L.L.C.2$125
Geron Corporation1$114
Lilly USA, LLC1$81
Genentech USA, Inc.1$18
AstraZeneca Pharmaceuticals LP1$18
Deciphera Pharmaceuticals Inc.1$18
ABBVIE INC.1$17

Products named: RYBREVANT, MONOFERRIC, DARZALEX, NUCALA, JEMPERLI, RYTELO, REBLOZYL, OPDIVO.

Industry payments across NJ — which companies pay providers there.